A claimant alleged that he had developed patented processes for the mass production of specific biopharmaceutical applications. He also alleged that the insured, a bio-pharmaceutical company, had engaged in false advertising, misappropriation of trade secrets, tortious interference and unfair competition. The claimant sought a declaration of the ownership of certain patents. The insured prevailed at trial. Defense costs totaled $2 million.